Spark Investment Management LLC Chimerix Inc Transaction History

Spark Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$2.3 - $3.72 $34,960 - $56,544	-15,200 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$1.27 - $2.33 $889 - $1,631	700 Added 4.83%	15,200 $21,000
Q4 2019 Feb 11, 2020	BUY	$1.3 - $2.72 $18,850 - $39,440	14,500 New	14,500 $29,000
Q2 2019 Aug 12, 2019	SELL	$2.05 - $4.32 $186,959 - $393,984	-91,200 Closed	0 $0
Q1 2019 May 07, 2019	SELL	$1.79 - $3.12 $168,797 - $294,216	-94,300 Reduced 50.84%	91,200 $191,000
Q4 2018 Feb 12, 2019	SELL	$2.24 - $3.9 $25,760 - $44,850	-11,500 Reduced 5.84%	185,500 $476,000
Q3 2018 Nov 13, 2018	BUY	$3.58 - $4.9 $15,036 - $20,580	4,200 Added 2.18%	197,000 $766,000
Q2 2018 Aug 08, 2018	BUY	$4.43 - $5.14 $854,104 - $990,991	192,800 New	192,800 $917,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.